▶ 調査レポート

3Dプリンター錠剤の世界市場:インサイト・予測

• 英文タイトル:Global 3D Printed Drugs Market Insights, Forecast to 2025

QYResearchが調査・発行した産業分析レポートです。3Dプリンター錠剤の世界市場:インサイト・予測 / Global 3D Printed Drugs Market Insights, Forecast to 2025 / QYR9ST02728資料のイメージです。• レポートコード:QYR9ST02728
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートでは、世界の3Dプリンター錠剤市場について調査・分析し、以下の構成でお届け致します。3Dプリンター錠剤の種類別には、スプリタム、その他に、用途別には、子ども、高齢者、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別3Dプリンター錠剤売上データ
・地域別3Dプリンター錠剤市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別3Dプリンター錠剤市場規模:スプリタム、その他
・用途別3Dプリンター錠剤市場規模:子ども、高齢者、その他
・主要メーカーの企業情報:Aprecia Pharmaceuticals、GlaxoSmithKline Plc、Hewlett Packard Caribe、BV、LLC、3D Printer Drug Machine、FabRx Ltd
・3Dプリンター錠剤の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 
The global 3D Printed Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the 3D Printed Drugs market based on company, product type, end user and key regions.

This report studies the global market size of 3D Printed Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of 3D Printed Drugs in these regions.
This research report categorizes the global 3D Printed Drugs market by top players/brands, region, type and end user. This report also studies the global 3D Printed Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aprecia Pharmaceuticals
GlaxoSmithKline Plc
Hewlett Packard Caribe
BV
LLC
3D Printer Drug Machine
FabRx Ltd

Market size by Product
Spritam
Others
Market size by End User
Children
Elderly
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global 3D Printed Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of 3D Printed Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global 3D Printed Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of 3D Printed Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of 3D Printed Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of 3D Printed Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 3D Printed Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global 3D Printed Drugs Market Size Growth Rate by Product
1.4.2 Spritam
1.4.3 Others
1.5 Market by End User
1.5.1 Global 3D Printed Drugs Market Size Growth Rate by End User
1.5.2 Children
1.5.3 Elderly
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global 3D Printed Drugs Market Size
2.1.1 Global 3D Printed Drugs Revenue 2014-2025
2.1.2 Global 3D Printed Drugs Sales 2014-2025
2.2 3D Printed Drugs Growth Rate by Regions
2.2.1 Global 3D Printed Drugs Sales by Regions
2.2.2 Global 3D Printed Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 3D Printed Drugs Sales by Manufacturers
3.1.1 3D Printed Drugs Sales by Manufacturers
3.1.2 3D Printed Drugs Sales Market Share by Manufacturers
3.1.3 Global 3D Printed Drugs Market Concentration Ratio (CR5 and HHI)
3.2 3D Printed Drugs Revenue by Manufacturers
3.2.1 3D Printed Drugs Revenue by Manufacturers (2014-2019)
3.2.2 3D Printed Drugs Revenue Share by Manufacturers (2014-2019)
3.3 3D Printed Drugs Price by Manufacturers
3.4 3D Printed Drugs Manufacturing Base Distribution, Product Types
3.4.1 3D Printed Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 3D Printed Drugs Product Type
3.4.3 Date of International Manufacturers Enter into 3D Printed Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global 3D Printed Drugs Sales by Product
4.2 Global 3D Printed Drugs Revenue by Product
4.3 3D Printed Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global 3D Printed Drugs Breakdown Data by End User

6 North America
6.1 North America 3D Printed Drugs by Countries
6.1.1 North America 3D Printed Drugs Sales by Countries
6.1.2 North America 3D Printed Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America 3D Printed Drugs by Product
6.3 North America 3D Printed Drugs by End User

7 Europe
7.1 Europe 3D Printed Drugs by Countries
7.1.1 Europe 3D Printed Drugs Sales by Countries
7.1.2 Europe 3D Printed Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe 3D Printed Drugs by Product
7.3 Europe 3D Printed Drugs by End User

8 Asia Pacific
8.1 Asia Pacific 3D Printed Drugs by Countries
8.1.1 Asia Pacific 3D Printed Drugs Sales by Countries
8.1.2 Asia Pacific 3D Printed Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific 3D Printed Drugs by Product
8.3 Asia Pacific 3D Printed Drugs by End User

9 Central & South America
9.1 Central & South America 3D Printed Drugs by Countries
9.1.1 Central & South America 3D Printed Drugs Sales by Countries
9.1.2 Central & South America 3D Printed Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America 3D Printed Drugs by Product
9.3 Central & South America 3D Printed Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa 3D Printed Drugs by Countries
10.1.1 Middle East and Africa 3D Printed Drugs Sales by Countries
10.1.2 Middle East and Africa 3D Printed Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa 3D Printed Drugs by Product
10.3 Middle East and Africa 3D Printed Drugs by End User

11 Company Profiles
11.1 Aprecia Pharmaceuticals
11.1.1 Aprecia Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Products Offered
11.1.5 Aprecia Pharmaceuticals Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Plc 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Plc 3D Printed Drugs Products Offered
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Hewlett Packard Caribe
11.3.1 Hewlett Packard Caribe Company Details
11.3.2 Company Business Overview
11.3.3 Hewlett Packard Caribe 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Hewlett Packard Caribe 3D Printed Drugs Products Offered
11.3.5 Hewlett Packard Caribe Recent Development
11.4 BV
11.4.1 BV Company Details
11.4.2 Company Business Overview
11.4.3 BV 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BV 3D Printed Drugs Products Offered
11.4.5 BV Recent Development
11.5 LLC
11.5.1 LLC Company Details
11.5.2 Company Business Overview
11.5.3 LLC 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 LLC 3D Printed Drugs Products Offered
11.5.5 LLC Recent Development
11.6 3D Printer Drug Machine
11.6.1 3D Printer Drug Machine Company Details
11.6.2 Company Business Overview
11.6.3 3D Printer Drug Machine 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 3D Printer Drug Machine 3D Printed Drugs Products Offered
11.6.5 3D Printer Drug Machine Recent Development
11.7 FabRx Ltd
11.7.1 FabRx Ltd Company Details
11.7.2 Company Business Overview
11.7.3 FabRx Ltd 3D Printed Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 FabRx Ltd 3D Printed Drugs Products Offered
11.7.5 FabRx Ltd Recent Development

12 Future Forecast
12.1 3D Printed Drugs Market Forecast by Regions
12.1.1 Global 3D Printed Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global 3D Printed Drugs Revenue Forecast by Regions 2019-2025
12.2 3D Printed Drugs Market Forecast by Product
12.2.1 Global 3D Printed Drugs Sales Forecast by Product 2019-2025
12.2.2 Global 3D Printed Drugs Revenue Forecast by Product 2019-2025
12.3 3D Printed Drugs Market Forecast by End User
12.4 North America 3D Printed Drugs Forecast
12.5 Europe 3D Printed Drugs Forecast
12.6 Asia Pacific 3D Printed Drugs Forecast
12.7 Central & South America 3D Printed Drugs Forecast
12.8 Middle East and Africa 3D Printed Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 3D Printed Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure 3D Printed Drugs Product Picture
Table 3D Printed Drugs Market Segments
Table Key Manufacturers 3D Printed Drugs Covered
Table Global 3D Printed Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global 3D Printed Drugs Sales Market Share by Product 2014-2025
Figure Spritam Product Picture
Table Major Manufacturers of Spritam
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global 3D Printed Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Children
Figure Elderly
Figure Others
Figure 3D Printed Drugs Report Years Considered
Figure Global 3D Printed Drugs Market Size 2014-2025 (Million US$)
Figure Global 3D Printed Drugs Sales 2014-2025 (K Units)
Table Global 3D Printed Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global 3D Printed Drugs Sales by Regions 2014-2019 (K Units)
Table Global 3D Printed Drugs Sales Market Share by Regions 2014-2019
Figure Global 3D Printed Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global 3D Printed Drugs Sales Market Share by Regions
Table Global 3D Printed Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global 3D Printed Drugs Revenue Market Share by Regions 2014-2019
Figure Global 3D Printed Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global 3D Printed Drugs Revenue Market Share by Regions
Table Global 3D Printed Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global 3D Printed Drugs Sales Share by Manufacturers (2014-2019)
Figure Global 3D Printed Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 3D Printed Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table 3D Printed Drugs Revenue Share by Manufacturers (2014-2019)
Figure 3D Printed Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers 3D Printed Drugs Price (2014-2019) (USD/Unit)
Table 3D Printed Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers 3D Printed Drugs Product Type
Table Date of International Manufacturers Enter into 3D Printed Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global 3D Printed Drugs Sales by Product (2014-2019) (K Units)
Table Global 3D Printed Drugs Sales Share by Product (2014-2019)
Figure Global 3D Printed Drugs Sales Market Share by Product (2014-2019)
Figure Global 3D Printed Drugs Sales Market Share by Product in 2018
Table Global 3D Printed Drugs Revenue by Product (2014-2019) (Million US$)
Table Global 3D Printed Drugs Revenue Share by Product (2014-2019)
Figure Global 3D Printed Drugs Revenue Market Share by Product (2014-2019)
Figure Global 3D Printed Drugs Revenue Market Share by Product in 2018
Table 3D Printed Drugs Price by Product 2014-2019 (USD/Unit)
Table Global 3D Printed Drugs Sales by End User (2014-2019) (K Units)
Table Global 3D Printed Drugs Sales Share by End User (2014-2019)
Figure Global Sales 3D Printed Drugs Market Share by End User (2014-2019)
Figure Global Sales 3D Printed Drugs Market Share by End User in 2018
Figure North America 3D Printed Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America 3D Printed Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America 3D Printed Drugs Sales by Countries (2014-2019) (K Units)
Table North America 3D Printed Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America 3D Printed Drugs Sales Market Share by Countries
Table North America 3D Printed Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America 3D Printed Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America 3D Printed Drugs Revenue Market Share by Countries
Figure United States 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States 3D Printed Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America 3D Printed Drugs Sales by Product (2014-2019) (K Units)
Table North America 3D Printed Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America 3D Printed Drugs Market Share by Product
Table North America 3D Printed Drugs Sales by End User (2014-2019) (K Units)
Table North America 3D Printed Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America 3D Printed Drugs Market Share by End User
Figure Europe 3D Printed Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe 3D Printed Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe 3D Printed Drugs Sales by Countries (2014-2019) (K Units)
Table Europe 3D Printed Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe 3D Printed Drugs Sales Market Share by Countries
Table Europe 3D Printed Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe 3D Printed Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe 3D Printed Drugs Revenue Market Share by Countries
Figure Germany 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe 3D Printed Drugs Sales by Product (2014-2019) (K Units)
Table Europe 3D Printed Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe 3D Printed Drugs Market Share by Product
Table Europe 3D Printed Drugs Sales by End User (2014-2019) (K Units)
Table Europe 3D Printed Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe 3D Printed Drugs Market Share by End User
Figure Asia Pacific 3D Printed Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific 3D Printed Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific 3D Printed Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific 3D Printed Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific 3D Printed Drugs Sales Market Share by Countries
Table Asia Pacific 3D Printed Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific 3D Printed Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific 3D Printed Drugs Revenue Market Share by Countries
Figure China 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific 3D Printed Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific 3D Printed Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific 3D Printed Drugs Market Share by Product
Table Asia Pacific 3D Printed Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific 3D Printed Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific 3D Printed Drugs Market Share by End User
Figure Central & South America 3D Printed Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America 3D Printed Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America 3D Printed Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America 3D Printed Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America 3D Printed Drugs Sales Market Share by Countries
Table Central & South America 3D Printed Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America 3D Printed Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America 3D Printed Drugs Revenue Market Share by Countries
Figure Brazil 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America 3D Printed Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America 3D Printed Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America 3D Printed Drugs Market Share by Product
Table Central & South America 3D Printed Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America 3D Printed Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America 3D Printed Drugs Market Share by End User
Figure Middle East and Africa 3D Printed Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa 3D Printed Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa 3D Printed Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa 3D Printed Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa 3D Printed Drugs Sales Market Share by Countries
Table Middle East and Africa 3D Printed Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa 3D Printed Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa 3D Printed Drugs Revenue Market Share by Countries
Figure GCC Countries 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa 3D Printed Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa 3D Printed Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa 3D Printed Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa 3D Printed Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa 3D Printed Drugs Market Share by Product
Table Middle East and Africa 3D Printed Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa 3D Printed Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa 3D Printed Drugs Market Share by End User
Table Aprecia Pharmaceuticals Company Details
Table Aprecia Pharmaceuticals 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aprecia Pharmaceuticals Recent Development

Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Recent Development

Table Hewlett Packard Caribe Company Details
Table Hewlett Packard Caribe 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hewlett Packard Caribe Recent Development

Table BV Company Details
Table BV 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BV Recent Development

Table LLC Company Details
Table LLC 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LLC Recent Development

Table 3D Printer Drug Machine Company Details
Table 3D Printer Drug Machine 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table 3D Printer Drug Machine Recent Development

Table FabRx Ltd Company Details
Table FabRx Ltd 3D Printed Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table FabRx Ltd Recent Development

Table Global 3D Printed Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global 3D Printed Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global 3D Printed Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global 3D Printed Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global 3D Printed Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global 3D Printed Drugs Sales Market Share Forecast by Product 2019-2025
Table Global 3D Printed Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global 3D Printed Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global 3D Printed Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global 3D Printed Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America 3D Printed Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America 3D Printed Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe 3D Printed Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe 3D Printed Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific 3D Printed Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific 3D Printed Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America 3D Printed Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America 3D Printed Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa 3D Printed Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa 3D Printed Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table 3D Printed Drugs Value Chain
Table 3D Printed Drugs Customers List
Table 3D Printed Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources